Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S 05985 combination versus angiotensin II receptor blocker/calcium channel blocker for essential hypertension
ISRCTN59214686Phase 3Completed
- Sponsor
- Servier
- Start
- Nov 2010
- Modality
- Small Molecules
01
Overview
Phase 3 trial of perindopril + indapamide + amlodipine and resomelagon in essential hypertension, sponsored by Servier. Started Nov 2010; status: completed.
02
Drugs
perindopril + indapamide + amlodipineresomelagon
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ISRCTN59214686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN59214686.